08J

8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine

Find entries where: 08J

is present as a standalone ligand in 2 entries

Find related ligands:

Chemical Component Summary
Name	8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
Synonyms	Midazolam
Identifiers	8-chloranyl-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
Formula	C₁₈ H₁₃ Cl F N₃
Molecular Weight	325.77
Type	NON-POLYMER
Isomeric SMILES	Cc1ncc2n1-c3ccc(cc3C(=NC2)c4ccccc4F)Cl
InChI	InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3
InChIKey	DDLIGBOFAVUZHB-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	36
Chiral Atom Count	0
Bond Count	39
Aromatic Bond Count	17

Drug Info: DrugBank

DrugBank ID	DB00683
Name	Midazolam
Groups	approved illicit
Description	Midazolam is a short-acting hypnotic-sedative drug with anxiolytic, muscle relaxant, anticonvulsant, sedative, hypnotic, and amnesic properties.[A173842] It belongs to a class of drugs called _benzodiazepines_. This drug is unique from others in this class due to its rapid onset of effects and short duration of action.[A173842] Midazolam is available by oral, rectal, intranasal, intramuscular (IM), and intravenous (IV) routes and has been used in various biomedical applications, including dentistry, cardiac surgery, and endoscopic procedures as pre-anesthetic medication, and as an adjunct to local anesthesia.[F2977] This drug was initially approved by the US FDA in 1985, and has been approved for various indications since.[FDA label] In late 2018, the intramuscular preparation was approved by the FDA for the treatment of status epilepticus in adults.[FDA label] In May 2019, the nasal spray of midazolam was approved for the acute treatment of distinctive intermittent, stereotypic seizure episodes in patients 12 years of age and older. Midazolam is considered a schedule IV drug in the United States due to the low potential for abuse and low risk of dependence.[L5074]
Synonyms	Midazolamum Midazolam maleate Midazolam Midazolam hydrochloride
Brand Names	Apo-midazolam Injectable 5 mg/ml Buccolam MKO Melt MKO Melt Dose Pack Versed Inj 5mg/ml Midazolam hydrochloride Nayzilam Midazolam Injection Sdz MKH Dose Pack Midazolam Injection USP Midazolam Injection Versed Inj 1mg/ml Seizalam Midazolam Injection BP Midazolam Midazolam HCl Midazolam Hydrochloride Apo-midazolam Injectable 1 mg/ml PMS-midazolam
Indication	Intravenous Indicated for promoting preoperative sedation, anxiolysis, anesthesia induction, or amnesia.[F2434] Intramuscular Indicated for the treatment of status epilepticus in adults.[FDA label] Nasal Indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patient’s usual seizure pattern in patients with epilepsy 12 years of age and older.[L6559]
Categories	Adjuvants, Anesthesia Anesthetics Anti-Anxiety Agents Benzodiazepine hypnotics and sedatives Benzodiazepines and benzodiazepine derivatives Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 CYP3A7 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted GABA Agents GABA Modulators Heterocyclic Compounds, Fused-Ring Hypnotics and Sedatives Nervous System Neurotransmitter Agents Psycholeptics Psychotropic Drugs Tranquilizing Agents Triazolobenzodiazepines UGT1A4 substrates
ATC-Code	N05CD08
CAS number	59467-70-8

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
GABA(A) Receptor	MRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRILDRLL...	unknown	positive allosteric modulator
GABA(A) Receptor Benzodiazepine Binding Site	MRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRILDRLL...	unknown	ligand
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate,inhibitor
UDP-glucuronosyltransferase 1-4	MARGLQVPLPRLATGLLLLLSVQPWAESGKVLVVPTDGSPWLSMREALRE...	unknown	substrate
Cytochrome P450 3A5	MDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNV...	unknown	substrate
Cytochrome P450 3A7	MDLIPNLAVETWLLLAVSLILLYLYGTRTHGLFKKLGIPGPTPLPFLGNA...	unknown	substrate
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682